The circuit court now expects the Trump administration to file a brief by March 20 explaining why it appealed the district court’s ruling and for Kelly’s legal team to file its reply brief by April 27 ...

Generate Biomedicines has filed for an IPO on the Nasdaq, seeking to raise upwards of $100 million for its AI-powered drug discovery operations. Incubated by Flagship Pioneering, Generate applies AI ...

Generate Biomedicines, Inc. (GENB) has filed to raise public capital in an IPO to advance its pipeline of treatment candidates, according to an SEC filing. The company is developing treatments for ...

Want to take a deep dive into American history? Every U.S. president since Herbert Hoover (and a few before) has a library dedicated to his life and time in office. These presidential libraries are ...

Katelyn is a writer with CNET covering artificial intelligence, including chatbots, image and video generators. Her work explores how new AI technology is infiltrating our lives, shaping the content ...

Leeron is a New York-based writer who specializes in covering technology for small and mid-sized businesses. Her work has been featured in publications including Bankrate, Quartz, the Village Voice, ...

Looking for ways to make some extra money this year? We've compiled a list of different passive income ideas to spark inspiration, including investing, real estate and a few niche options, like ...

Antibodies are a wonderful example of what natural selection, operating over millions of years of evolution, can engineer. Drug developers searching for novel, non-natural antibody therapeutics, ...